PTJ
CATX icon

Paul Tudor Jones’s Perspective Therapeutics CATX Stock Holding History

Paul Tudor Jones’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.7K Sell
18,106
-15,840
-47% -$59.8K ﹤0.01% 3423
2026
Q1 		$142K Buy
+33,946
New +$143K ﹤0.01% 3429
2025
Q1 		– Sell
-28,577
Closed -$91.2K – 3100
2024
Q4 		$91.2K Buy
+28,577
New +$233K ﹤0.01% 2911

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Paul Tudor Jones's CATX Position: Q2 2026 in Review

Paul Tudor Jones reduced its Perspective Therapeutics (CATX) stake by 47% in Q2 2026, selling an estimated $59.8K and leaving 18,106 shares worth $61.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Paul Tudor Jones first reported a position in CATX in Q4 2024 and has held it in 3 quarters since. The position peaked at $142K in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Paul Tudor Jones held 18,106 shares of Perspective Therapeutics worth $61.7K as of Q2 2026.
  • Paul Tudor Jones sold 15,840 Perspective Therapeutics shares in Q2 2026, an estimated $59.8K.
  • Perspective Therapeutics made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3423 holding.
  • Paul Tudor Jones first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Paul Tudor Jones's Perspective Therapeutics position peaked at $142K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.